Tenon Medical (NASDAQ:TNON) vs. Alpha Tau Medical (NASDAQ:DRTS) Head-To-Head Comparison

Alpha Tau Medical (NASDAQ:DRTS) and Tenon Medical (NASDAQ:TNON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, profitability, institutional ownership, valuation, earnings and dividends.

Earnings & Valuation

This table compares Alpha Tau Medical and Tenon Medical”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alpha Tau Medical	N/A	N/A	-$29.16 million	($0.45)	-5.82
Tenon Medical	$3.32 million	2.29	-$15.58 million	($27.23)	-0.09

Tenon Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Alpha Tau Medical and Tenon Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Alpha Tau Medical	N/A	-38.62%	-29.89%
Tenon Medical	-413.88%	-1,785.88%	-164.26%

Analyst Recommendations

This is a breakdown of recent ratings and price targets for Alpha Tau Medical and Tenon Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alpha Tau Medical	0	0	2	0	3.00
Tenon Medical	0	0	2	0	3.00

Alpha Tau Medical presently has a consensus target price of $8.00, indicating a potential upside of 205.34%. Tenon Medical has a consensus target price of $5.50, indicating a potential upside of 127.27%. Given Alpha Tau Medical’s higher possible upside, research analysts clearly believe Alpha Tau Medical is more favorable than Tenon Medical.

Volatility & Risk

Alpha Tau Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, Tenon Medical has a beta of 1.89, meaning that its share price is 89% more volatile than the S&P 500.

Insider & Institutional Ownership

2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 22.7% of Tenon Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 4.7% of Tenon Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Alpha Tau Medical beats Tenon Medical on 6 of the 11 factors compared between the two stocks.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.